These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27097910)

  • 1. Underutilization of gene expression profiling for early-stage breast cancer in California.
    Cress RD; Chen YS; Morris CR; Chew H; Kizer KW
    Cancer Causes Control; 2016 Jun; 27(6):721-7. PubMed ID: 27097910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results.
    Press DJ; Ibraheem A; Dolan ME; Goss KH; Conzen S; Huo D
    Breast Cancer Res Treat; 2018 Feb; 168(1):207-220. PubMed ID: 29181717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of provider factors and race on uptake of breast cancer gene expression profiling.
    Reeder-Hayes KE; Wheeler SB; Baggett CD; Zhou X; Meng K; Roberts MC; Carey LA; Meyer AM
    Cancer; 2018 Apr; 124(8):1743-1751. PubMed ID: 29338090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer.
    Roberts MC; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes KE; Carey LA; Troester MA; Wheeler SB
    J Clin Oncol; 2016 Jan; 34(2):130-8. PubMed ID: 26598755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study.
    Davis BA; Aminawung JA; Abu-Khalaf MM; Evans SB; Su K; Mehta R; Wang SY; Gross CP
    J Natl Compr Canc Netw; 2017 Mar; 15(3):346-354. PubMed ID: 28275035
    [No Abstract]   [Full Text] [Related]  

  • 6. A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands.
    Simons MJHG; Machielsen PM; Spoorendonk JA; Ignacio T; Drost PB; Jacobs T; de Jongh FE
    J Med Econ; 2024; 27(1):445-454. PubMed ID: 38436289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
    Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
    Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tracking and feedback registry to reduce racial disparities in breast cancer care.
    Bickell NA; Shastri K; Fei K; Oluwole S; Godfrey H; Hiotis K; Srinivasan A; Guth AA
    J Natl Cancer Inst; 2008 Dec; 100(23):1717-23. PubMed ID: 19033569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment.
    Hassett MJ; Schymura MJ; Chen K; Boscoe FP; Gesten FC; Schrag D
    Cancer; 2016 Feb; 122(3):420-31. PubMed ID: 26536043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of the 21-Gene Assay Among Women With Node-Positive, Hormone Receptor-Positive Breast Cancer.
    Roberts MC; Kurian AW; Petkov VI
    J Natl Compr Canc Netw; 2019 Jun; 17(6):662-668. PubMed ID: 31200352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trend and survival benefit of Oncotype DX use among female hormone receptor-positive breast cancer patients in 17 SEER registries, 2004-2015.
    Zhang L; Hsieh MC; Petkov V; Yu Q; Chiu YW; Wu XC
    Breast Cancer Res Treat; 2020 Apr; 180(2):491-501. PubMed ID: 32060781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
    Chen L; Li CI
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65.
    O'Neill SC; Isaacs C; Lynce F; Graham DM; Chao C; Sheppard VB; Zhou Y; Liu C; Selvam N; Schwartz MD; Potosky AL
    Breast Cancer Res; 2017 Mar; 19(1):45. PubMed ID: 28359319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncotype DX Test Receipt among Latina/Hispanic Women with Early Invasive Breast Cancer in New Jersey: A Registry-Based Study.
    Acuna N; Plascak JJ; Tsui J; Stroup AM; Llanos AAM
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34065945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low utility of Oncotype DX® in the clinic.
    Ricks-Santi LJ; McDonald JT
    Cancer Med; 2017 Mar; 6(3):501-507. PubMed ID: 28145091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis.
    Carlson JJ; Roth JA
    Breast Cancer Res Treat; 2013 Aug; 141(1):13-22. PubMed ID: 23974828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial disparities in treatment and survival among women with early-stage breast cancer.
    Hershman D; McBride R; Jacobson JS; Lamerato L; Roberts K; Grann VR; Neugut AI
    J Clin Oncol; 2005 Sep; 23(27):6639-46. PubMed ID: 16170171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
    Jackson LC; Camacho F; Levine EA; Anderson RT; Stewart JH
    Am J Surg; 2008 Feb; 195(2):164-9. PubMed ID: 18096124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample.
    Griggs JJ; Hawley ST; Graff JJ; Hamilton AS; Jagsi R; Janz NK; Mujahid MS; Friese CR; Salem B; Abrahamse PH; Katz SJ
    J Clin Oncol; 2012 Sep; 30(25):3058-64. PubMed ID: 22869890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in pancreas cancer care.
    Abraham A; Al-Refaie WB; Parsons HM; Dudeja V; Vickers SM; Habermann EB
    Ann Surg Oncol; 2013 Jun; 20(6):2078-87. PubMed ID: 23579872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.